ScripThe uncertainty created by potential tariffs and US healthcare strategies has seen some senior pharma figures express concern about the impact on M&A but GSK CEO Emma Walmsley is confident that de
HBW InsightGSK plc ’s ledger of settlements and other developments in its defense against Zantac liability complaints got its biggest addition yet on 9 October with the firm’s announcement of settling around 80,
HBW InsightNext month Haleon plc will become the first consumer health company to launch an FDA-approved OTC treatment for erectile dysfunction. In what it described as a “bold step,” Haleon backed UK R&D
HBW InsightHBW Insight is shining a spotlight on the work of regulatory affairs specialists operating in and supporting the consumer health and cosmetics industries. We are profiling this important role, hearing